Publications by authors named "Mitchell Hull"

Claim this Profile
A
Author Correction: Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.
Laura Riva, Shuofeng Yuan, Xin Yin, Laura Martin-Sancho, Naoko Matsunaga, Mitchell V Hull

Nature· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological inhibition of CLK2 activates YAP by promoting alternative splicing of AMOTL2.
Maya L Bulos, Edyta M Grzelak, Chloris Li-Ma, Emily Chen, Mitchell Hull

Elife· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A covalent inhibitor of the YAP-TEAD transcriptional complex identified by high-throughput screening.
Kayla Nutsch, Lirui Song, Emily Chen, Mitchell Hull, Arnab K Chatterjee

RSC Chem Biol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological inhibition of CLK2 activates YAP by promoting alternative splicing of AMOTL2.
Maya L Bulos, Edyta M Grzelak, Chloris Li-Ma, Emily Chen, Mitchell Hull

bioRxiv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High throughput screening for drugs that inhibit 3C-like protease in SARS-CoV-2.
Emery Smith, Meredith E Davis-Gardner, Ruben D Garcia-Ordonez, Tu-Trinh Nguyen, Mitchell Hull

SLAS Discov· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safe drugs with high potential to block malaria transmission revealed by a spleen-mimetic screening.
Mario Carucci, Julien Duez, Joel Tarning, Irene García-Barbazán, Aurélie Fricot-Monsinjon, Mitchell V Hull

Nat Commun· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of potent small molecule inhibitors of SARS-CoV-2 entry.
Sonia Mediouni, Huihui Mou, Yuka Otsuka, Joseph Anthony Jablonski, Robert Scott Adcock, Mitchell Hull

SLAS Discov· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.
Martin A Redhead, C David Owen, Lennart Brewitz, Amelia H Collette, Petra Lukacik, Mitchell Hull

Sci Rep· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
YAP-dependent proliferation by a small molecule targeting annexin A2.
Sophia Z Shalhout, Peng-Yu Yang, Edyta M Grzelak, Kayla Nutsch, Sida Shao, Mitchell Hull

Nat Chem Biol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening the CALIBR ReFRAME Library in Search for Inhibitors of Biofilm Formation.
Gina Wall, Emily Chen, Mitchell V Hull, Jose L Lopez-Ribot

Front Cell Infect Microbiol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug repurposing screens identify chemical entities for the development of COVID-19 interventions.
Malina A Bakowski, Nathan Beutler, Karen C Wolff, Melanie G Kirkpatrick, Emily Chen, Mitchell V Hull

Nat Commun· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.
Martin A Redhead, C David Owen, Lennart Brewitz, Amelia H Collette, Petra Lukacik, Mitchell Hull

Sci Rep· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical Inhibition of ENL/AF9 YEATS Domains in Acute Leukemia.
Leopold Garnar-Wortzel, Timothy R Bishop, Seiya Kitamura, Natalia Milosevich, Joshua N Asiaban, Mitchell V Hull

ACS Cent Sci· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Throughput Screening for Drugs That Inhibit Papain-Like Protease in SARS-CoV-2.
Emery Smith, Meredith E Davis-Gardner, Ruben D Garcia-Ordonez, Tu-Trinh Nguyen, Mitchell Hull

SLAS Discov· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.
Laura Riva, Shuofeng Yuan, Xin Yin, Laura Martin-Sancho, Naoko Matsunaga, Mitchell V Hull

Nature· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae.
Christopher A Rice, Beatrice L Colon, Emily Chen, Mitchell V Hull, Dennis E Kyle

PLoS Negl Trop Dis· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small-Molecule Stimulators of NRF1 Transcriptional Activity.
Jonathan Iaconelli, Lara Ibrahim, Emily Chen, Mitchell Hull, Peter G Schultz

Chembiochem· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sulfur(VI) Fluoride Exchange (SuFEx)-Enabled High-Throughput Medicinal Chemistry.
Seiya Kitamura, Qinheng Zheng, Jordan L Woehl, Angelo Solania, Emily Chen, Mitchell V Hull

J Am Chem Soc· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-Based Ligand Discovery for the ENL YEATS Domain.
Joshua N Asiaban, Natalia Milosevich, Emily Chen, Timothy R Bishop, Justin Wang, Mitchell V Hull

ACS Chem Biol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals.
Laura Riva, Shuofeng Yuan, Xin Yin, Laura Martin-Sancho, Naoko Matsunaga, Mitchell V Hull

bioRxiv· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Throughput Screening of the ReFRAME Library Identifies Potential Drug Repurposing Candidates for .
Jean A Bernatchez, Emily Chen, Mitchell V Hull, Case W McNamara, James H McKerrow

Microorganisms· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitors.
Yu-Jin Kim, Beatrice Cubitt, Emily Chen, Mitchell V Hull, Arnab K Chatterjee

Antiviral Res· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Kirromycins with Anti- Wolbachia Activity from Streptomyces sp. CB00686.
Zhengren Xu, Shi-Ming Fang, Malina A Bakowski, Mostafa E Rateb, Dong Yang, Mitchell V Hull

ACS Chem Biol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infections.
Malina A Bakowski, Roohollah Kazem Shiroodi, Renhe Liu, Jason Olejniczak, Baiyuan Yang, Mitchell V Hull

Sci Transl Med· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis.
Jeff Janes, Megan E Young, Emily Chen, Nicole H Rogers, Sebastian Burgstaller-Muehlbacher, Mitchell V Hull

Proc Natl Acad Sci U S A· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis